医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from the STAMPEDE multiarm, multistage, randomised controlled trial

广告
第一作者: James,N.D.
作者单位: Medical Research Council Clinical Trials Unit, London, United Kingdom [1] Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, United Kingdom [2] Royal Devon and Exeter, Exeter, United Kingdom [3] Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom [4] Royal Preston Hospital, Preston, United Kingdom, University of Manchester, Manchester, United [5] Institute of Cancer Research, Royal Marsden Hospital, Sutton, United Kingdom [6] Prostate Cancer Support Federation, Stockport, United Kingdom [7] Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom [8] Churchill Hospital, Oxford, United Kingdom [9] Inselspital, Bern, Switzerland [10] School of Medicine, Cardiff University, Cardiff, United Kingdom [11] Christie and Salford Royal Hospitals Foundations Trusts, Manchester University, Manchester, United [12] Royal Hallamshire Hospital, Sheffield, United Kingdom [13] Singleton Hospital, Swansea, United Kingdom [14] School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom [15]
发布时间 2013-11-20
提交
  • 浏览4
The lancet oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷